このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Advanced Multisensorial System for Automatic Assessment of Neurological Disorders in Smart Spaces-Universidad Rey Juan Carlos (URJC) (NeurEYE-URJC)

2026年10月30日 更新者:Rosa M Martínez Piédrola、Universidad Rey Juan Carlos

Advanced Multisensorial System for Automatic Assessment of Neurological Disorders in Smart Spaces-URJC

Neurological diseases affect people's cognitive and physical abilities, limiting their functional independence and causing disability, which in many cases, is progressive and degenerative. Being able to perform activities of daily living is a challenge in these pathologies. Currently, different observational tools are administered to assess the degree of functional limitation in basic and instrumental Activities of Daily Living (ADL). However, the assessment must be performed in an ecological and real context to obtain objective information and ensure the most accurate assessment possible. To this end, it is necessary to consider the factors that influence the performance of ADLs and also on the quality of their execution, especially in this population in which the stressful situation of direct observation by an evaluator has a direct influence on the final score. Advanced Multisensorial System for Automatic Assessment of Neurological Disorders in Smart Spaces (NeurEYE) aims to develop technological tools to extract from sensory systems typical of intelligent spaces and with the help of signal processing and machine learning processes based on artificial intelligence, indicators of neurological impairment that influence functional capacity and function/dysfunction components while observing the performance of an activity of daily living. In addition, NeurEYE would provide as a scientific breakthrough the accurate description of subjects' limitations in the controlled assessment environment within the routine patient context. The NeurEye project will allow the clinical validation of a multisensory system that, through the detection of functional limitations in the ADLs of patients with neurological disorder, allows to establish the level of disability of the subjects. In addition, the qualitative and quantitative description of the functional alterations of the person with neurological disorders and, the elimination of the subjective bias of the examiner, will allow the generation of individualized clinical and statistical reports according to sex, activity, etc. that will be clinically useful in the early detection, diagnosis, and adaptation of rehabilitation treatments to the specific functional needs of neurological disorders.

調査の概要

詳細な説明

The project has been funded by the Ministry of Science, Innovation and universities in the 2023 Call - "Knowledge Generation Projects" and actions for the training of predoctoral research staff associated with these projects. The Advanced Multisensorial System for Automatic Assessment of Neurological Disorders in Smart Spaces - Universidad Rey Juan Carlos (NeurEYE-URJC) project ref. PID2024-156576OB-C32 is part of a combined project with the University of Seville and the University of Alcalá de Henares. The NeurEYE-URJC project plays a leading role in the design of the methodology, and clinical validation, with the collaboration of the NeurEYE-Universidad de Alcalá (NeurEYE-UAH) and NeurEYE-Universidad de Sevilla (NeurEYE-US) projects being necessary to provide detailed feedback on the current and foreseeable possibilities of cutting-edge technology for the analysis of human behaviour. This proposal is linked to the "Health" priority of the State Plan for Scientific Research. In addition, the project is also directed towards the second pillar of the Global Challenges within those of Horizon Europe. More specifically, towards some of the main objectives of the Health Cluster.

Neurological diseases are one of the main causes of disability. In Spain, this type of pathology is responsible for 44% of disability due to chronic diseases and 50% of the years lost due to disability. ADLs are fundamental skills for maintaining and caring for oneself, therefore, the inability to perform them properly results in a state of dependency, which implies the need for some kind of help or assistance and, therefore, entails high financial and care costs.

However, there are important limitations in their application: first, no "gold standard" has been determined for the evaluation of functionality, second, the information they detail is not related to the quality of execution, third, they have practical limitations such as long administration times, fourth, the subjectivity of the evaluator and the biases it produces; gender and culture, interviewee biases for feeling observed by another person and in the case of interviews, recall biases that can occur in self-administered tools, because they are based on the recall of performance in the ADL and we can find that those who are evaluated consider their problem as unimportant, are aware of their problem but deny it or do not report it accurately and/or realistically. In addition, we may encounter evaluator bias, since observational assessment instruments require professional training to administer them.

The use of technology is an innovative strategy that can bring great improvements in the evaluation of functional performance, as it can objectively measure performance in an activity and the required behaviors through para-based monitoring.

研究の種類

観察的

入学 (推定)

50

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

    • Madrid
      • Alcorcón、Madrid、スペイン、28922
        • Facultad de Ciencias de la Salud. Universidad Rey Juan Carlos
        • コンタクト:
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

The Control group sample (subjects without pathology over the age of 18) will be obtained using non-probability convenience sampling. Recruitment will be carried out from the researchers' immediate circle. The experimental group sample (adults diagnosed with a neurological disease) is proposed through a non-probabilistic sampling of consecutive cases from collaborating hospitals and patient associations [Spanish Federation of Parkinson's Disease Associations, the Synaptia Vithas Neuroscience Institute, the University Hospital of Guadalajara and the National Paraplegic Hospital of Toledo].

説明

Inclusion Criteria:

  • Time since diagnosis.
  • Mini-Mental State Examination (Folstein) score between 10 and 30 (no impairment or moderate cognitive impairment).
  • Barthel Index score between 100 and 61 (independent or mildly dependent).
  • On stable medical treatment for three months prior to assessment.

Exclusion Criteria:

  • Diagnosis of a musculoskeletal disorder or diagnosis of any cardiovascular, respiratory, or metabolic disease, or other conditions that may interfere.
  • Failure to sign the informed consent form.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:CASE_CONTROL
  • 時間の展望:CROSS_SECTIONAL

コホートと介入

グループ/コホート
介入・治療
Healthy people

Undiagnosed persons will be evaluated by the NeurEYE system performing activities of daily living.

Patterns of action will be recorded to establish outcome measures in healthy population.

The data to be captured are exclusively video and audio recordings, and different signals from smartwatches (mainly related to movement).

Addittionaly, the clinical evaluation of the performance of these activities will be carried out according to the assessment scales to be defined in the project.

The results of this evaluation will be exclusively used in the training of the automatic systems developed in the project and in order to establish a correlation between the captured observations (video, audio, smart watches signals) and the diagnostic assessment.

People with neurological diseases

People with neurological diseases will be evaluated by the NeurEYE system performing activities of daily living.

Patterns of action will be recorded, to establish outcome measures in healthy population.

The data to be captured are exclusively video andaudio recordings, and different signals from smartwatches (mainly related to movement).

Addittionaly, the clinical evaluation of the performance of these activities will be carried out according to theassessment scales to be defined in the project.

The results of this evaluation will be exclusively used in the training of the automatic systems developed in the project and in order to establish a correlation between the captured observations (video, audio, smart watches signals) and the diagnostic assessment.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Cognitive assessment
時間枠:First year

Rivermead Behavioural Memory Test (RBMT) is a standardized memory assessment tool designed to evaluate how memory problems affect a person's daily functioning. It primarily assesses prospective memory, verbal memory, visual memory, recognition, and orientation through tasks that simulate everyday situations.

It is a widely used test in clinical and research settings, with adequate psychometric properties (reliability and validity) and sensitivity for detecting memory impairments associated with brain damage, neurodegenerative diseases, and other neurological conditions.

It is administered individually by a trained professional. It includes various functional tasks, such as recalling names, routes, messages, or personal belongings.

First year
Grip strength assessment
時間枠:First year

To measure grip strength the Jamar dynamometer is a standardized instrument used to measure handgrip strength, a relevant indicator of upper limb muscle function and overall functional status. It is frequently used in rehabilitation, neurology, geriatrics, and musculoskeletal assessment.

It is considered the gold standard for grip strength assessment. It exhibits high reliability, validity, and reproducibility, making it widely used in both clinical practice and research.

First year
Manual dexterity
時間枠:First year

The Nine Hole Peg Test (NHPT) is a standardized test used to assess fine motor dexterity and upper limb motor coordination. It measures how quickly a person can place and remove nine pegs from a pegboard and is widely used in neurology and rehabilitation.

It is a well-validated tool with good reliability, validity, and sensitivity for detecting changes in manual function. It is frequently used in research and clinical practice with populations affected by stroke, multiple sclerosis, Parkinson's disease, and other neurological conditions.

First year
Cognitive abilities
時間枠:First year

The Trail Making Test (TMT) is a standardized neuropsychological test that assesses processing speed, visual attention, cognitive flexibility, and executive functions. It can be administered by occupational therapists. It consists of two parts: Part A involves connecting numbers in sequence, and Part B involves alternating numbers and letters in a predetermined order.

It is one of the most widely used and validated tests in neuropsychology. It exhibits adequate psychometric properties, good reliability, and sensitivity for detecting cognitive impairments associated with brain damage, aging, dementia, and other neurological diseases.

First year
Language
時間枠:First year

The Quick Aphasia Battery (QAB) is an standardized tool designed to quickly assess the presence and severity of language impairments in individuals with aphasia. It evaluates various language domains, including auditory comprehension, verbal expression, repetition, naming, reading, and language fluency.

It is a validated test with good psychometric properties, allowing for the reliable identification and quantification of language deficits. It has proven useful in both clinical and research settings, particularly in patients with stroke and other acquired neurological injuries.

First year
Behavioral
時間枠:First Year

Lille Apathy Rating Scale (LARS) is a standardized tool designed to assess apathy in individuals with neurological disorders. It analyzes different dimensions of this syndrome, including motivation, interest, initiative, participation in activities, and emotional response.

It is a widely used and validated scale, especially in Parkinson's disease and other neurological conditions. It exhibits good internal consistency, high inter-rater reliability, and adequate construct and criterion validity, allowing for the reliable identification and quantification of apathy severity.

First Year
Depression
時間枠:First year

Mini-DASS (Mini Depression Anxiety Stress Scales). Designed to assess emotional distress across three main dimensions: depression, anxiety, and stress. It is used as a screening tool to identify emotional symptoms and monitor changes over time.

It is a measure based on the theoretical model of the Depression Anxiety Stress Scales, which has been widely validated in general and clinical populations. The abbreviated versions have shown adequate validity and reliability, maintaining a good ability to discriminate between depressive, anxious, and stress symptoms.

Good internal consistency for the total score and its subscales, with Cronbach's alpha coefficients generally above 0.70. Adequate convergent validity with other measures of depression, anxiety, and emotional well-being. Good sensitivity for detecting mild, moderate, and high levels of psychological distress. A factor structure consistent with the dimensions of depression, anxiety

First year
Apraxia
時間枠:First Year

Test of Upper Limb Apraxia (TULIA). This is a standardized tool designed to assess upper limb apraxia, that is, difficulties in planning and executing learned movements voluntarily despite preserving basic strength, sensation, and comprehension. It evaluates the imitation and execution of both transitive (object use) and intransitive (communicative) movements.

It is a widely validated test for the assessment of apraxia following stroke and other neurological injuries. It exhibits high reliability, validity, and discriminative power, making it one of the reference tools for the clinical and research assessment of upper limb apraxia.

First Year
Attentional deficit
時間枠:First Year

Star Cancellation Test is a screening test used to assess unilateral spatial hemineglect, a common impairment following brain injury, especially after a right hemisphere stroke. It evaluates a person's ability to visually explore space and identify stimuli distributed on a sheet of paper.

It is one of the most widely used tests for detecting spatial hemineglect. It has demonstrated good clinical validity and sensitivity for identifying visuospatial attention deficits, and is included in widely used batteries in neurology and neurorehabilitation, such as the Behavioral Inattention Test (BIT).

First Year
Sensibility 1
時間枠:First year

Algometry (pressure pain threshold measurement) is a standardized technique used to assess sensitivity to mechanical pain by measuring the pressure pain threshold (PPT). It allows for the objective quantification of the minimum pressure that elicits a painful sensation and is frequently used in patients with musculoskeletal disorders, chronic pain, and neurological conditions.

Algometry is a widely used method in research and clinical practice for pain assessment. It exhibits good validity and reliability when performed with standardized protocols, and is particularly useful for monitoring changes in pain sensitivity and response to treatments.

First year
Sensibility 2
時間枠:Second year

The Visual Analogue Scale (VAS) is a self-report tool used to evaluate the intensity of perceived pain. It typically consists of a 10 cm line whose ends represent "no pain" and "worst imaginable pain," allowing for a simple quantification of the subjective experience of pain.

It is one of the most widely used pain measures in clinical practice and research. It exhibits adequate validity, reliability, and sensitivity to change, and is considered a gold standard for assessing pain intensity and monitoring the response to therapeutic interventions.

Second year
Motor function
時間枠:First year

Box and Block Test (BBT) This is a standardized test used to assess gross manual dexterity and unilateral upper extremity motor function. It measures a person's ability to grasp, carry, and release wooden blocks from one compartment to another within a specified time.

It is one of the most widely used tools for assessing manual function in rehabilitation, neurology, and occupational therapy. It exhibits strong psychometric properties and is sensitive in detecting motor deficits and functional changes following therapeutic intervention.

First year
Functional gait
時間枠:First Year

Functional Gait Assessment (FGA) is an observational scale designed to assess functional gait and dynamic balance during various tasks that challenge postural control. It analyzes an individual's ability to walk under different conditions, such as changes in speed, head turns, walking with obstacles, quick turns, and stair climbing.

It is a widely used tool in neurology, geriatrics, and rehabilitation. Derived from the Dynamic Gait Index (DGI), it exhibits good psychometric properties and a high capacity for identifying dynamic balance impairments and fall risk in individuals with neurological and vestibular disorders.

First Year
Postural control
時間枠:First year

Sensory Organization Test (SOT). This instrumental test assesses postural control and balance by analyzing how a person uses and integrates visual, vestibular, and somatosensory information to maintain stability. It is one of the most widely used tests within computerized dynamic posturography.

The SOT is considered a gold standard for the objective assessment of balance. It has high validity and reliability and is widely used in research and clinical practice to evaluate balance impairments associated with neurological, vestibular, and musculoskeletal disorders.

First year

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年11月1日

一次修了 (推定)

2026年11月1日

研究の完了 (推定)

2028年11月1日

試験登録日

最初に提出

2026年10月26日

QC基準を満たした最初の提出物

2026年10月26日

最初の投稿 (実際)

2026年11月2日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月4日

QC基準を満たした最後の更新が送信されました

2026年10月30日

最終確認日

2026年10月1日

詳しくは

本研究に関する用語

追加の関連 MeSH 用語

その他の研究ID番号

  • A726
  • 2025 (米国 NIH グラント/契約)
  • 2025/00420/006 (その他の助成金/資金番号:AGENCIA ESTATAL INVESTIGACION)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

No personal data of participants will be shared

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する